| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.087 | 0.06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |